XtalPi , a leading global technology company in integrating artificial intelligence (AI) and robotics for drug and materials discovery, announced a transformative strategic collaboration with DoveTree Medicines, a biotechnology pioneer founded by renowned drug developer Dr. Gregory Verdine. The collaboration, worth up…
Supreme Group, a next-generation agency platform purpose-built for healthcare and life sciences marketing and communications, announced it has acquired Pivot Design, a globally recognized agency known for infusing health brands with humanity and bold storytelling. This latest milestone marks Supreme Group's ninth acqu…
The VERTEX Companies, LLC, a global professional services firm delivering expert, forensic, construction project advisory, and management and regulatory consulting services, has acquired ADAMS Management Services Corporation, a nationally recognized leader in healthcare program and project management. This strategic a…
Argosy Healthcare Partners (AHP), a lower middle market private equity firm focused exclusively on healthcare, announced a recapitalization and partnership with O.R. Staffing Solutions (ORSS). ORSS provides workforce solutions for operating rooms in acute care hospitals and ambulatory surgery centers (ASCs). AHP is th…
Alveolus Bio, a pioneering respiratory drug development biotech company founded by Dr. Vivek Lal from University of Alabama at Birmingham, AL, has announced a strategic financing round led by Shilpa Medicare Limited, a prominent global pharmaceutical company with extensive expertise in respiratory therapeutics manufac…
Dx&Vx has signed its first-ever global out-licensing agreement since its establishment. DXVX announced that it has entered into a co-development and license agreement valued at approximately USD 220 million with a U.S.-based biotech company for its mRNA-based cancer vaccine. Revenue sharing post-commercialization…
Tigermed, a leading global provider of clinical research solutions across the full lifecycle of global biopharmaceutical and medical device products, announces the completion of its acquisition of CRO company Micron,Inc. Following the acquisition, Micron will be integrated into Tigermed's global network as a key enti…
GSK plc announced it has entered into agreements with Hengrui Pharma to develop up to 12 innovative medicines, adding significant new growth opportunities to the company beyond 2031. The programmes were selected to complement GSK’s extensive Respiratory, Immunology & Inflammation (RI&I) and Oncology pipeline, …
Elpis Biopharmaceuticals, a clinical-stage cell therapy company developing bispecific armored CAR-T therapies for solid tumors, announced the signing of a Memorandum of Understanding (MOU) with the National Cancer Centre Singapore (NCCS). The partnership aims to support collaborative cell therapy research and clinical…
Bristol Myers Squibb and Bain Capital announced the creation of a new independent biopharmaceutical company (“NewCo”) focused on developing new therapies for autoimmune diseases that address significant unmet needs of patients. The newly formed company launches with five immunology assets in-licensed from BMS and a $3…
Page 31 of 37